Last reviewed · How we verify

NCT03377374

L. Reuteri ATCC PTA 5289 & L. Reuteri DSM 17938 for the Treatment of Children With Pharyngitis and/or Tonsillitis

Completed NA Last updated 20 June 2019
What this trial tests

NA trial testing Probiotic in Pharyngitis in 70 participants. Completed in 11 February 2019.

Timeline
28 December 2017
Primary endpoint
30 May 2018
11 February 2019

Quick facts

Lead sponsorInnovacion y Desarrollo de Estrategias en Salud
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment70
Start date28 December 2017
Primary completion30 May 2018
Estimated completion11 February 2019
Sites1 location across Mexico

Drugs / interventions tested

Conditions studied

Sponsor

Innovacion y Desarrollo de Estrategias en Salud — full company profile →

Who can join

Adults 6 Months to 5, any sex, with Pharyngitis or Tonsillitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

RCT in children (6m to 5y) with pharyngitis and/or tonsillitis who will be allocated to receive for 10 days L. reuteri DSM 17938 + L. reuteri ATCC PTA 5289) at a dose of 2x10\^8 Colony Forming Units (CFU). Five drops are to be taken twice a day (in the morning and in the evening) or placebo drops, as treatment for clinical condition. Duration of symptoms and reduction of pain (odynophagia) severity during treatment will be measured as primary outcome

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

Other recruiting trials for Pharyngitis

Currently open trials in the same condition.

Other Innovacion y Desarrollo de Estrategias en Salud trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03377374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing